Related Experiment Videos
Assessment of relationship between acute ischemic stroke and heart disease--protocol of a prospective observational
Michal Kral1, David Skoloudik, Daniel Sanak
1Comprehensive Stroke Center, Department of Neurology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic. kral_michal@centrum.cz
Insights
This study investigates the link between acute ischemic stroke and acute coronary syndrome. Improved identification of these concurrent conditions is crucial for targeted treatment and secondary prevention strategies.
Area of Science:
- Cardiology
- Neurology
- Biomarkers
Background:
- Stroke and acute myocardial infarction are leading causes of death and disability.
- Risk factors for cardiovascular and cerebrovascular diseases overlap.
- Clear recommendations for managing concurrent myocardial damage in stroke patients are lacking.
Purpose of the Study:
- To improve the identification of patients experiencing both acute coronary syndrome and acute ischemic stroke.
- To establish clear management and secondary prevention strategies for these patients.
Main Methods:
- Prospective observational trial of 500 ischemic stroke patients within 12 hours of onset.
- Comprehensive assessments including neuroimaging, cardiac biomarkers (NT-proBNP, cTnT), ECG, echocardiography, and neurosonology.
- Coronary angiography for patients with positive findings for acute myocardial ischemia.
Main Results:
- Analysis of epidemiological characteristics and correlations between stroke etiology and cardiac markers.
- Evaluation of the relationship between infarction volume, ECG findings, and cardiac troponin T (cTnT) levels.
- Statistical evaluation of coronary angiography findings against cTnT levels and ECG data.
Conclusions:
- Accurate identification of patients with concurrent acute ischemic stroke and acute coronary syndrome is essential.
- These patients require specific treatment protocols.
- Effective secondary prevention of ischemic events can be enhanced through improved identification.
Background:
Stroke and acute myocardial infarction are the leading causes of death and disability in industrialized countries. Multiple interactions exist between the various forms of cardiovascular and cerebrovascular diseases, and risk factors for development of stroke and major cardiovascular events are similar. There is currently no clear link between acute coronary syndrome and stroke, although it has been repeatedly described. In addition, there are currently no clear recommendations for how to proceed in the case of signs of myocardial damage in patients with acute stroke and how to manage the next follow-up. METHODS-DESIGN: In this prospective observational trial, 500 consecutive ischemic stroke patients admitted at the Comprehensive Stroke Center will be enrolled within 12 h from stroke onset. The set of examinations will consist of: 1) Acute brain computed tomography or magnetic resonance imaging 2) Laboratory tests: A) within 12 h from stroke onset: NT pro B-type of natriuretic peptide, pro-atrial natriuretic peptide, creatinekinase MB, troponin T (cTnT), interleukin 6, procalcitonin, high sensitive C-reactive protein and D-dimers. B) control level of cTnT after 4 h from admission C) non-acute laboratory samples within 60 h from stroke onset: glycated haemoglobine, serum lipids; 3) Electrocardiogram (ECG) on admission and 4 h from stroke onset; 4) Transesophageal or transthoracal echocardiography and 24-h ECG-Holter within 15 days from stroke onset; 5) Neurosonological examination within 60 h from stroke onset; 6) Thirty patients with a positive finding of acute myocardial ischemia (ECG, cTnT) will be examined by coronary angiography (CAG); 7) Epidemiological data will be acquired.
Statistics:
The epidemiological characteristics of the whole sample of patients; correlation between differences between group of cardioembolic ischemic stroke patients and group of patients with ischemic stroke of another etiology; correlation of infarction volume on DWI-MRI with the level of cTnT; correlation of the ECG findings with the level of cTnT and clinical signs; correlation of the CAG findings with level of cTnT and ECG findings will be statistically evaluated at the 5% level of statistical significance.
Conclusion:
The main goal of the project is to improve identification of patients with acute coronary syndrome and with concurrent acute ischemic stroke as these patients require specific treatment and secondary prevention of ischemic events.
Trial Registration:
Clinicaltrials.gov NCT01541163.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome III: Diagnostic Studies
Ischemic Stroke l: Introduction
Acute Coronary Syndrome I: Introduction
Ischemic Stroke ll: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations